funguscme.orgWelcome to FungusCME.org - FungusCME.org is the official continuing education site of the collaborat

ion of the Mycoses Study Group Education & Research Consortium and Terranova Medica. HOME ABOUT CONTACT Welcome to FungusCME.org FungusCME.org is the official continuing education site of the collaboration of the Mycoses Study Group Education & Research Consortium and Terranova Medica. The MSG-ERC’s mission includes setting the annual educational and research agendas for mycology and providing top-quality continuing education initiatives to MSG-member institutions and to other institutions and practitioners throughout the United States and globally. We thank our generous commercial supporters for their commitment to our live and web-based continuing education efforts. We hope you enjoy the variety of continuing activities present on this site, and we welcome your input on ongoing educational needs in the area of invasive mycoses. Current Activities: New Activity! Treatment Failure in Mycology: Addressing the Root Cause This case-based CME/CPE/CNE activity is focused on addressing causes of treatment failure in serious fungal infections to improve patient outcomes. Using a multidisciplinary approach, the faculty will address inadequate testing, antifungal resistance, adherence issues, source control, and pharmacologic issues, including inadequate use of therapeutic drug monitoring. The cases will span resistant dermatophytes, coccidioidomycosis, candidemia, and an invasive mold infection. Click Here to Learn More, or use the links below to register or login. New Activity! Case Studies in Optimal Management of Invasive Candidiasis This multimedia CME/CPE enduring activity from the live MSGERC Town Hall held on July 7, 2023, discusses the newest trends in the management of invasive candidiasis. The expert faculty discuss hospital and health care-associated infection scenarios: a patient coming in from a long-term acute care hospital (LTACH), an invasive fungal infection in a stem cell transplant patient, and an intra-abdominal infection in a hospitalized surgical patient. Click Here to Learn More, or use the links below to register or login. Community-Acquired Pneumonia: When to Think Fungus *Activity available for review, but it no longer carries credit. This CME/CNE/CPE activity will explore community-acquired pneumonia cases, illustrating when to consider coccidioidomycosis, blastomycosis, and histoplasmosis endemic mycoses as potential etiologies. The activity will feature use of CDC/MSGERC/CSG algorithms to recognize patients at risk for these infections as well as diagnostic strategies. This activity was developed for a target audience of primary care providers, specialists who prescribe biologics, pulmonologists, as well as urgent care and emergency medicine providers who see patients with community acquired pneumonia. Click Here to Learn More, or use the links below to register or login. Challenging Invasive Fungal Infections: Current and Emerging Pharmacologic Strategies *Activity available for review, but it no longer carries credit. The optimal management of invasive fungal infections requires a collaborative approach focused on optimal agent selection, pharmacologic optimization, and a clear strategy to identify and address treatment failure. For some pathogens, the challenge is further exacerbated by the limitations of existing regimens. Fortunately, emerging therapeutic approaches show promise for a range of invasive mycoses. In this activity, featuring cases from the virtual live event MSGERC Town Hall: Challenging Invasive Fungal Infections , mycology experts illustrate strategies to optimize the management of challenging invasive mold and Coccidioides infections. The activity features mycology experts Drs Luis Ostrosky-Zeichner, George R. Thompson III, and James Lewis, with additional commentary from Dr Nathan Wiederhold. Click Here to Learn More, or use the links below to register or login. Managing Invasive Candidiasis: Key Strategies to Make a Difference *Activity available for review, but it no longer carries credit. In this activity, Drs Ostrosky-Zeichner and Peter Pappas illustrate strategies to make a difference in the management of invasive candidiasis. Using an infographic approach to reinforce key concepts, they make a compelling call to action for more state-of-the-art management of this common fungal infection. Click Here to Learn More, or use the links below to register or login. Challenging Invasive Fungal Infections: Risk Assessment and Diagnosis *Activity available for review, but it no longer carries credit. Thinking fungus, diagnosing the fungal pathogen to the genus and species level, and addressing antifungal resistance are key steps to improving outcomes for invasive fungal infections (IFIs). This activity, featuring cases from the virtual live event MSGERC Town Hall: Challenging Invasive Fungal Infections , is designed to help clinicians identify at-risk patients and secure the IFI diagnosis. It will highlight the problem with low awareness of endemic mycoses as potential causes of CAP as well as the importance of appropriate use of antifungal susceptibility testing. The activity features mycology experts Drs Luis Ostrosky-Zeichner, George R. Thompson III, and Nathan Wiederhold,with additional commentary by Dr James Lewis. Click Here to Learn More, or use the links below to register or login. COVID-19–Associated Invasive Fungal Infections: Expert Guidance on Cases From the Community *Activity available for review, but it no longer carries credit. Patients with severe COVID-19 who require mechanical ventilation are at increased risk for invasive fungal infections (IFIs), which increase morbidity and mortality. As part of a CDC Cooperative agreement, the faculty for the COVID-19–associated Fungal Infections Educational Initiative have developed a series of tools for diagnosing and managing these IFIs. In this interactive, case-based activity, mycology experts Drs George R. Thompson, III; Dimitrios Kontoyiannis; and Minh-Hong Thi Nguyen apply these tools in challenging COVID-19–associated IFI cases submitted by community clinicians. The activity addresses COVID-19—associated pulmonary aspergillosis (CAPA), COVID-19associated mucormycosis, and coccidioidomycosis relapse after recovery from COVID-19. Click Here to Learn More, or use the links below to register or login. COVID-19—Associated Invasive Fungal Infections: Multidisciplinary Management *Activity available for review, but it no longer carries credit. Patients with severe COVID-19 who require mechanical ventilation are at increased risk for invasive fungal infections (IFIs). However, many clinicians do not have a strategy to screen for these infections. As part of a CDC Cooperative agreement, the faculty for the COVID-19–Associated Fungal Infections Educational Initiative ( https://covidandfungus.org/ ) have developed a series of tools to assist healthcare providers in recognizing and managing these infections. In this interactive, case-based activity, expert faculty from the disciplines of infectious diseases/medical mycology, pulmonology, intensive-care medicine, and infectious diseases pharmacy weigh in on challenging COVID-19–associated IFI cases. Join them as they work together to develop strategies for the management of candidemia, COVID-19—associated pulmonary aspergillosis, and cryptococcosis in patients with severe COVID-19. Click Here to Learn More, or use the links below to register or login. Click below for a bonus video from the Transformative Care faculty in which they discuss strategies to overcome barriers to optimal invasive mold management. Cutaneous Lesions Post CAR T-Cell Therapy Case 2 of Transformative Care for Invasive Mold Infections: Strategies that Make a Difference in Patient Outcomes *Activity available for review, but it no longer carries credit. In the second case of this initiative moderated by Dr Luis Ostrosky-Zeichner, Dr Matthew Lunning presents a case of cutaneous lesions post CAR T-cell therapy in a patient with large...